Supreme Court rules on securities fraud pleading requirements

[JURIST] The US Supreme Court [official website] on Tuesday ruled that plaintiffs bringing securities fraud claims cannot establish economic loss necessary for such claims by showing that stock prices were inflated at the time of purchase. In Dura Pharmaceuticals, Inc. v. Broudo [Duke Law School case backgrounder], 03-932, the Court overturned a Ninth Circuit decision that plaintiffs could simply prove the stock price was inflated due to misrepresentations. In the class action case, the plaintiffs had claimed securities fraud by Dura Pharmaceuticals, which they alleged misrepresented pending FDA approval of an asthmatic spray device. Read the Court's unanimous opinion [PDF text], per Justice Breyer. AP has more.

 

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.